Journal of the American Medical Directors Association
Letter to the EditorAdverse Drug Reactions Associated With Cholinesterase Inhibitors—Sequence Symmetry Analyses Using Prescription Claims Data
Section snippets
Methods
Sequence symmetry analyses (SSAs)7 were conducted using data from a 10% random sample of dispensing data from the PBS between March 2005 and May 2016. These data comprised patient-level records of all reimbursed medications dispensed by Australian pharmacies. SSA is a signal detection technique used in the postmarketing surveillance of prescription medications that compares the sequence of incident dispensing of an index and marker medication.7 The index medication is considered the exposure,
Results
In total, 11,695 people were initiated on a cholinesterase inhibitor between March 2007 and May 2015. There were 1202 people with incident dispensing for nausea, 1079 for dyspepsia, 389 for seizures, 348 for diarrhea, 261 for urinary incontinence, 1698 for depression, 807 for anxiety, and 963 for insomnia within 52 weeks before or after initiation of the index cholinesterase inhibitor. Incident dispensing was significantly higher for diarrhea (ASR, 1.42; 95% CI, 1.14–1.77), anxiety (ASR, 1.16;
Discussion
The main finding of this study was an increase in first dispensing of medications for seizures, anxiety, insomnia, nausea, and diarrhea following initiation of cholinesterase inhibitors. There was an inverse association between initiation of cholinesterase inhibitors and initiation of medications for dyspepsia and depression.
The WHO database included 247 spontaneous reports of seizures.3 Our data substantiates these ADR reports. Visual inspection of Figure 1 suggests that incident dispensing of
Acknowledgments
The authors thank Dr. Te-yuan Chyou from the University of Otago for his help with R programming. The authors would also like to acknowledge the Australian Government, Department of Human Services for provision of the data.
References (14)
- et al.
A randomized placebo-controlled discontinuation study of cholinesterase inhibitors in institutionalized patients with moderate to severe alzheimer disease
J Am Med Dir Assoc
(2016) - et al.
Time to treatment initiation in people with alzheimer disease: A meta-analysis of randomized controlled trials
J Am Med Dir Assoc
(2016) - et al.
Signs and symptoms indicative of potential adverse drug reactions in homecare patients
J Am Med Dir Assoc
(2013) - et al.
Adverse drug reactions reported with cholinesterase inhibitors: An analysis of 16 years of individual case safety reports from VigiBase
Ann Pharmacother
(2015) Cholinesterase inhibitors for Alzheimer's disease
Cochrane Database Syst Rev
(2006)- et al.
Under-reporting of adverse drug reactions: A systematic review
Drug Saf
(2006) Evidence of depression provoked by cardiovascular medication: A prescription sequence symmetry analysis
Epidemiology
(1996)
Cited by (6)
Prescribing Cascades: How to Detect Them, Prevent Them, and Use Them Appropriately
2022, Deutsches Arzteblatt InternationalPrescribing cascades in community-dwelling adults: A systematic review
2022, Pharmacology Research and PerspectivesOral administration of the food-derived hydrophilic antioxidant ergothioneine enhances object recognition memory in mice
2021, Current Molecular PharmacologyScreening for Adverse Drug Reactions in Dementia Patients on Cholinesterase Inhibitor Therapy
2020, Journal of the American Geriatrics SocietyTrends and Predictors of Oral Anticoagulant Use in People with Alzheimer's Disease and the General Population in Australia
2019, Journal of Alzheimer's Disease
J.I. was supported by the National Health and Medical Research Council Fellowship (grant number 1072137).